期刊文献+

抗反转录病毒药物血液毒性反应患者外周血CD4~+ T和CD8~+ T细胞计数与病毒载量相关分析 被引量:5

下载PDF
导出
摘要 获得性免疫缺陷综合症(acquired immune defi-ciency syndrome,AIDS),即艾滋病,是人类因为感染人类免疫缺陷病毒(human immunodeficiency virus,HIV)后导致免疫缺陷,并发一系列机会性感染及肿瘤,严重者可导致死亡。在疾病的发展过程中,病毒载量与CD4+T细胞水平已成为判定HIV感染者病程、预测临床进展以及评价抗病毒药物疗效的重要指标[1-2]。
作者 刘志斌
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第8期869-870,共2页 Chinese Journal of Cellular and Molecular Immunology
基金 国家“艾滋病和病毒肝炎等重大传染病防治”科技重大专项“十一五”计划课题(2008ZX10005-003B) 国家中医药管理局中医药重点学科建设项目(国中医药发[2009]30号) 郑州市科技创新团队建设项目(10CXTD140) 河南省教育科学“十一五”规划2010年课题(2010-JKGHAZ-0047)
  • 相关文献

参考文献8

  • 1DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents-A Working Group of the Office of AIDS Research Advisory Council ( OA- RAC). Guidelines for the use of antiretroviral agents in HIV-l-infec- ted adults and adolescents. 2011 [ EB/OL]. [ 2011 - 03 - 30 ]. http : //aidsinfo. nih. gov/contenffiles/ duhandAdolescentGL, pdf.
  • 2Carbone J, Gil J, Benito JM, et al. Increased levels of activated subsets of CIM T cells add to the propaostie value of low CD4 T cell counts in a cohort of HIV infected drug users[J]. AIDS, 2000, 14 (18) : 2823 -2829.
  • 3徐向升,张政,顾兰兰,王福生.共抑制分子BTLA在慢性HIV-1感染中的特点及与疾病进展的相关性研究[J].细胞与分子免疫学杂志,2009,25(12):1158-1160. 被引量:9
  • 4Wang H, Nishanian P, Fahey JL. Characterization of Immune 3uppression by a Synthetie HIV gp41 Peptide [ J ]. Cell Immunol, 1995, 161 : 236 -243.
  • 5Carre N, Boufassa F, Hubert JB, et al. Predictive value of viral load and other markers for progression to clinical AIDS after CIM + cell count fails below 200/microL. SEROCO & HEMOCO Study Group [J]. Int J Epidemiol, 1998, 27(5) : 897 -903.
  • 6Paul ME, Shearer WT, Kozinetz CA, et al. Comparison of CD^8+ T- cell subsets in HIV-infected rapid progxessor children versus non-rapid progressor children[J]. J Allergy Clin Immunol, 2001, 108(2) : 258 - 264.
  • 7鲍作义,李林,庄道民,刘思扬,刘永健,李松,李敬云.HIV感染者CD4/CD8细胞与病毒载量的关系[J].中国公共卫生,2003,19(11):1380-1381. 被引量:22
  • 8王临虹,方利文,龚双燕,等.HIV感染孕产妇CIM^+T淋巴细胞与病毒载量分析[J].中华国产医学杂志,2007,20(5):289-292.

二级参考文献15

  • 1Douek DC, Picker LJ, Koup RA. T cell dynamics in HIV-1 infection [J]. Annu Rev lmmunol, 2003, 21:265 -304.
  • 2Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection : causes and consequences [ J ]. J Pathol, 2008, 214 ( 2 ) : 231 -241.
  • 3Cadogan M, Dalgleish AG. HIV immunopathogenesis and strategies for intervention[J]. Lancet Infect Dis, 2008, 8( 11 ) : 675 -684.
  • 4Watanabe N, Gavrieli M, Sedy JR, et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 [ J ]. Nat Immunol, 2003, 4(7): 670-679.
  • 5Sedy JR, Gavrieli M, Potter KG, et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator[J]. Nat Immunol, 2005, 6( 1 ) : 90 -98.
  • 6Zhang JY, Zhang Z, Wang X, et al. PD-1 up-regulation is correlated with HIV-specific memory CD8^+ T-cell exhaustion in typical progressors but not in long-term nonprogressors[ J ]. Blood, 2007, 109 (11 ) : 4671 - 4678.
  • 7Kaufmann DE, Kavanagh DG, Pereyra F, et al. Upregulation of CTLA-4 by HIV-specific CD4^+ T ceils correlates with disease progression and defines a reversible immune dysfunction [J]. Nat Immunol, 2007, 8(11) : 1246 -1254.
  • 8Ware CF. Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways[ J]. Immunol Rev, 2008, 223 : 186 - 201.
  • 9Krieg C, Han P, Stone R, et al. Functional analysis of B and T lymphocyte attenuator engagement on CD4^+ and CD8^+ T cells[ J ]. J Immunol, 2005, 175(10) : 6420 -6427.
  • 10Wang XF, Chen YJ, Wang Q, et al. Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells [ J ]. Tissue Antigens, 2007, 69(2) : 145 - 153.

共引文献29

同被引文献55

  • 1郜桂菊,张福杰,姚均,赵红心,卢联合,李鑫.HIV感染者/AIDS患者CD_4^+细胞计数与机会性感染对应关系的临床分析[J].中国艾滋病性病,2005,11(4):241-243. 被引量:87
  • 2Wang H, Nishanian P, Fahey JL. Characterization of immune sup-pression by a synthetic HIV gp41 peptide[ J]. Cell Immunol, 1995,161(2): 236 - 243.
  • 3Carr6 N,Boufassa F,Hubert JB,et al. Predictive value of viral loadand other markers for progression to clinical AIDS after CD4 + cellcount falls below 200/microL. SEROCO & HEMOCO Study Group[J]. Int J Epidemiol, 1998,27(5) : 897 - 903.
  • 4Paul ME, Shearer WT, Kozinetz CA, et al. Comparison of CD8 +Tcell subsets in HIV-infected rapid progressor children versus non-rapid progressor children [ J ]. J Allergy Clin Immunol, 2001,108(2): 258-264.
  • 5Navaneethapandian PG,Karunaianantham R, Subramanyan S, et al.CD4 + T-lymphocyte count/CD8 + T-lymphocyte count ratio: surro-gate for HIV infection in infants[ J] . J Trap Pediatr, 2012,58(5):394 -397.
  • 6Freel SA, Saunders KO, Tomaras GD, CD8+ T-cell-mediatedcontrol of HIV-1 and SIV infection[ J]. Immunol Res, 2011, 49(1-3): 135 -146.
  • 7World Health Oi^anization. WHO case definitions of hiv for surveil-lance and revised clinical staging and immunological classification ofhiv-related disease in adults and cliildren[S]. 2007.
  • 8Goonetilleke N, Liu MKP, Salazar-Conzalez JF, et al. The first Tcell response to transmitted/founder virus contributes to the control ofacute viremia in HIV-1 infection[ J]. J Exp Med, 2009 , 206(6):1253 -1272.
  • 9Porichis F, Kaufmann DE. HIV-specific CD4 T cells and immunecontrol of viral replication[ J]. Curt Opin HIV AIDS, 2011,6(3):174-180.
  • 10黄丹红,唐国瑶,周海文.临床医从性研究概况[J].医学综述,2009,15(8):1242-1244. 被引量:8

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部